Bonventre P F, Nickol A D, Ball E J, Michael J G, Bubel H C
J Reticuloendothel Soc. 1982 Jul;32(1):25-35.
This report addresses the question whether Meth A (methylcholanthrene-induced fibrosarcoma) tumor bearing Balb/c mice are able to develop specific antimicrobial immunity. Although specific suppressor T lymphocytes appeared during tumor growth which prevented expression of antitumor immunity, the development of protective immunity to L monocytogenes, S. pneumoniae or ectromelia virus infections was unimpaired. The Meth A tumor produced a soluble immunosuppressive factor which inhibited lymphocyte and macrophage functions in vitro. Tumor growth failed to inhibit the formation of immunoglobulin essential to antipneumococcal immunity, or the development of a specific acquired cellular resistance of primary importance in immunity to listeria and ectromelia virus infections. That tumor growth did not interfere with the development of cell mediated immunity was demonstrated by the effective transfer of antilisteria immunity by immune spleen from tumor-bearing mice.
本报告探讨了携带甲基胆蒽诱导的纤维肉瘤(Meth A)的Balb/c小鼠是否能够产生特异性抗菌免疫。尽管在肿瘤生长过程中出现了特异性抑制性T淋巴细胞,从而阻止了抗肿瘤免疫的表达,但对单核细胞增生李斯特菌、肺炎链球菌或埃可病毒感染的保护性免疫的发展并未受到损害。Meth A肿瘤产生了一种可溶性免疫抑制因子,该因子在体外可抑制淋巴细胞和巨噬细胞的功能。肿瘤生长未能抑制抗肺炎球菌免疫所必需的免疫球蛋白的形成,也未能抑制对李斯特菌和埃可病毒感染免疫至关重要的特异性获得性细胞抵抗力的发展。携带肿瘤的小鼠的免疫脾对李斯特菌免疫的有效转移证明,肿瘤生长并未干扰细胞介导免疫的发展。